Sort   by:  
 Page size 
ProteomicsMouse myoblast fusion - Separating myoblast differentiation from muscle cell fusion using IGF-I and the p38 MAP kinase inhibitor SB202190
The p38 MAP kinases play critical roles in skeletal muscle biology, but the specific processes that they regulate remain poorly defined. Here we find that activity of p38α/β is important not only for early phases of myoblast differentiation, but also in later stages of myocyte fusion and myofibrill...
ORGANISM(S): Mus musculus (Mouse) 
2018-10-24 | PXD002413 | Pride
Mouse Myoblast Differentiation Fusion 
GenomicsTranscriptome analysis of mesenchymal glioma-propagating cells treated with p38MAPK inhibitor (SB202190)
Transcriptome analysis of mesenchymal glioma-propagating cells treated with p38MAPK inhibitor (SB202190)
PRJNA870445 | ENA
UnknownSB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation.
Not available
S-EPMC9954675 | biostudies-literature
Unknownp38 MAPK inhibitor SB202190 suppresses ferroptosis in the glutamate-induced retinal excitotoxicity glaucoma model.
Not available
S-EPMC11034608 | biostudies-literature
UnknownPERK activation by SB202190 ameliorates amyloidogenesis via the TFEB-induced autophagy-lysosomal pathway.
Not available
S-EPMC8876914 | biostudies-literature
UnknownA stress response p38 MAP kinase inhibitor SB202190 promoted TFEB/TFE3-dependent autophagy and lysosomal biogenesis independent of p38.
Not available
S-EPMC7264467 | biostudies-literature
UnknownSB202190-induced cell type-specific vacuole formation and defective autophagy do not depend on p38 MAP kinase inhibition.
Not available
S-EPMC3154272 | biostudies-literature
TranscriptomicsRNA-seq of human melanoma cell line A375m2 treated with SB202190 OR BIRB796 against DMSO-treated controls
Melanoma cells can switch between a more differentiated, proliferative phenotype and a dedifferentiated, invasive phenotype in response to signals from the environment. We found that p38 MAPK inhibitors SB202190 and BIRB796 induce phenotype switching from the dedifferentiated, invasive phenotype to ...
ORGANISM(S): Homo sapiens 
2020-11-28 | E-MTAB-9273 | biostudies-arrayexpress
GenomicsRNA-seq of human melanoma cell line A375m2 treated with SB202190 OR BIRB796 against DMSO-treated controls
RNA-seq of human melanoma cell line A375m2 treated with SB202190 OR BIRB796 against DMSO-treated controls
PRJEB39122 | ENA
UnknownSeparating myoblast differentiation from muscle cell fusion using IGF-I and the p38 MAP kinase inhibitor SB202190.
Not available
S-EPMC4593770 | biostudies-literature
Sort   by:  
 Page size